| Identification | Back Directory | [Name]
Palbociclib Impurity 38 | [CAS]
2270982-31-3 | [Synonyms]
Desacetyl Butoxyvinyl Polbociclib
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(1-butoxyethenyl)-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | [Molecular Formula]
C28H37N7O2 | [MOL File]
2270982-31-3.mol | [Molecular Weight]
503.64 |
| Hazard Information | Back Directory | [Uses]
Desacetyl Butoxyvinyl Palbociclib is an analog of Palbociclib (P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
|